Exposure to ozone has been associated with cardiovascular mortality, but the underlying biological mechanisms are not yet understood.
A irborne particulate matter with a diameter of 2.5 μm or less (PM 2.5 ) has often been reported to be associated with the cardiovascular toxic effects of air pollution mixtures and ozone (O 3 ) with respiratory illness. 1, 2 However, there is increasing evidence that O 3 , independent of PM 2.5 , is also associated with cardiovascular mortality.
3,4 For example, O 3 has been associated with increases in mortality due to embolism and thrombosis, 5 ischemic heart disease, 3 heart failure, 4 and stroke. 6 However, not all studies reporting associations of O 3 with cardiovascular outcomes found that the associations were independent from particulate matter and other gaseous pollutants, such as nitrogen dioxide (NO 2 ) and sulfur dioxide (SO 2 ). 7, 8 Other studies have found nonsignificant or seemingly "beneficial" associations between O 3 and cardiovascular outcomes. 9, 10 The uncertainty in epidemiologic findings of O 3 cardiovascular effects is further enhanced by the limited understanding of biological mechanisms underlying the epidemiologic associations.
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The relative uniformity of lifestyle patterns and proximity of participants living and working together at a work campus in Changsha City, China, presented a unique opportunity to monitor pollutants in indoor and outdoor air and to measure changes in the levels of biomarkers pertinent to cardiorespiratory disease risk. The cardiovascular biomarkers used in this study have all been associated with air pollution exposure in previous studies, 12 although not necessarily with O 3 specifically. This study also includes lung function measures that have consistently been associated with O 3 concentration in short-term, controlled-exposure experiments. 11 In addition, this setting facilitated the manipulation of indoor PM 2.5 and O 3 concentrations through the use of various filtration technologies in all the participants' residences and offices. Filtration provided an opportunity to generate different temporal patterns between O 3 and PM 2.5 exposures, which helped to disentangle the effects of these 2 major pollutants.
Methods

Study Subjects
We recruited 89 healthy white-collar workers living and working at the Broad Company Campus (Broad Town) in suburban Changsha, China. Each participant completed a questionnaire and underwent basic metabolic blood panel screenings for previous medical conditions to ensure a healthy baseline status. All participants had to be older than 18 years, work in one of 2 Broad Town offices, spend at least 4 nights each week in the dormitories, and be free from major chronic diseases as self-reported by the participants. In addition, abnormal blood lipid levels or markers of kidney, liver, or other metabolic dysfunction were grounds for exclusion. The ethics committee of the Shanghai First People's Hospital and the campus institutional review board of Duke University approved the study protocol. Explicit written consent was obtained from all participants. The present exploration focusing on pathophysiologic mechanisms of O 3 cardiovascular effects used data collected in field experiments in which indoor PM 2.5 concentrations were manipulated through varying filtration technologies to remove particulate matter entering the offices and dormitory rooms. These filters included minibag filters, electrostatic precipitators, and high-efficiency particulate air filters, which had aPM 2.5 removal efficiency of approximately 50%, 60%, and >99%, respectively. Electrostatic precipitators generated approximately 13.5 parts per billion (ppb) of incidental O 3 in the downstream air ducts, corresponding to a 3-ppb increase in steady state indoor concentrations 13 (eMethods in the Supplement). On different dates, 1 or more of these filtration technologies were used in the offices and dormitories.
Outcome Measurements
We measured the following biomarkers: exhaled breath condensate (EBC) malondialdehyde (MDA) for pulmonary oxidative stress 14 ; fractional exhaled nitric oxide (FeNO) 15 and the sum of EBC nitrite and nitrate (EBCNN) for pulmonary inflammation 14 ; forced expiratory volume in the first second (FEV 1 ), forced vital capacity (FVC), and FEV 1 :FVC ratio for lung function; C-reactive protein (CRP) for systemic inflammation 16 ; urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) for oxidative stress 17 ; brachial systolic blood pressure (SBP) and diastolic blood pressure (DBP) for vascular tone 18 ; brachial augmentation index (AI) and carotid-femoral pulse wave velocity (PWV) for arterial stiffness 19 ; soluble P-selectin (sCD62P) for platelet activation 20 ; and von Willebrand factor (VWF) for hemostasis.
21
Each participant was assessed 4 times over a 9-week period (from December 2, 2014, to January 30, 2015), with about 2 weeks in between assessments. Efforts were made to conduct all sessions for each participant on the same day of the week and at the same time of day, although work schedules necessitated some rescheduling. No sessions were scheduled within a day following a trip off campus.
Each session started with a venous blood and urine collection at 8 AM, followed throughout the day by any order of breath and EBC collections as well as blood pressure and arterial stiffness measurements, with spirometry always conducted last. Blood samples were centrifuged, and plasma aliquots were stored at −30°C before analysis for sCD62P, CRP, and VWF using an enzyme-linked immunosorbent assay method (R&D Systems for CRP and sCD62P; RayBiotech for VWF). Urine samples were immediately frozen for later solidphase extraction and liquid chromatography-mass spectrometry analysis for 8-OHdG. 22 Breath sample collection and analyses, spirometry, blood pressure, AI, and PWV measurements were conducted using standard procedures (eMethods in the Supplement).
Exposure Measurements
Outdoor PM 2.5 ,O 3 ,NO 2 , and SO 2 concentrations were measured at a government station 4.5 km from the study site. This station was predominantly upwind of the study site, and there were few major roadways and other local air pollution sources between the station and the study site. A comparison of the concentrations measured simultaneously at both sites showed a slope of 1.03 and R 2 of 0.998 for PM 2.5 and a slope of 0.97 and R 2 of 0.988 for O 3 in least squares linear regressions. Indoor PM 2.5 mass concentration and O 3 concentration were continuously measured in the 2 involved offices during the day and in 2 dormitory rooms per night using field-calibrated (against a primary method at the study location) nephelometers for PM 2.5 concentration measurement (SidePak AM510; TSI Inc) and a UV absorption monitor for O 3 concentration measurement (Model 205; 2B Tech) (eMethods in the Supplement). These measurements were used to establish indoor/ outdoor (I/O) ratios taking into account known indoor sources and filtration conditions (see eTable 2 in the Supplement), which were later used to estimate hourly averages for PM 2.5 and O 3 concentrations outside of the monitoring times. These I/O ratios were found to be within 25% of measured I/O ratios during monitoring times. Because NO 2 and SO 2 were not affected by the filtration conditions, these were not measured indoors. Instead, I/O ratios of 0.8 for NO 2 and 0.5 for SO 2 were assumed for all indoor spaces on the basis of physical characteristics of the dormitories and offices coupled with previous relevant literature. 23, 24 Time-activity questionnaire data were integrated with indoor and outdoor O 3 and PM 2.5 hourly mean concentrations to calculate 24-hour exposure concentrations. The assumed I/O ratios for unknown indoor environments were 0.35 for O 3 and 0.8 for PM 2.5 according to previous findings in lightly sealed indoor spaces 25, 26 and expectations for structures in the Changsha region. Because the study was organized with approximately 2-week breaks between biomarker measurements, 2-week exposure concentrations were estimated as representative of "subchronic" exposure effects (eMethods in the Supplement).
Statistical Analysis
Depending on data distribution, values of certain biomarkers were natural logarithm-transformed in statistical analyses (Supplementary Methods in the Supplement). Linear mixed models with participant-specific intercepts were used to analyze concentration-response associations between each biomarker and each exposure measure. The use of participantspecific intercepts in mixed models accounts for the correlation between within-participant repeated measurements and precludes the need to control for participant characteristics that do not change between measurements (eg, age). Twopollutant models for all combinations of 24-hour or 2-week exposures were performed to test whether the associations observed in the single-pollutant models remained after controlling for a second pollutant. All models controlled for 24-hour mean ambient temperature and time spent in a room with a smoker as an approximation of secondhand smoke exposure. Because we expected an unequal influence of certain covariates on the biomarkers, we used a backward stepwise model selection method to select the following additional covariates for each model: respiratory infection status, menstruation status, day of the week, and hours since the participant last ate (see covariates in eTable 5 in the Supplement). Multiple testing-corrected P values were obtained using the Benjamini-Yekutieli method of reducing the false discovery rate while allowing for an arbitrary dependence structure in the predictor and outcome variables. 27 A 2-sided P =. 05 indicated statistical significance. In Benjamini-Yekutieli multiple testing correction, the new, higher statistical significance level was P = .05. Sensitivity analyses included models excluding all smokers and ex-smokers, all observations reporting secondhand smoke exposure, or outlying values from the models. We also assessed 5 separate models by controlling for 1 of the following in the main model: (1) all 4 of the aforementioned stepwise method-selected covariates, (2) curvilinear associations with temperature using a cubic spline, (3) relative humidity, (4) wind direction and speed, and (5) interaction between a building filtration condition and a pollutant. All calculations were made using the "nlme," "openair," and "stats" packages in R version 3.2.3 (R Project for Statistical Computing).
Results
Participant Characteristics
Study participant characteristics are listed in Table 1 .Ofthe 89 participants, 25 (28%) were women and the mean (SD) age was 31.5 (7.6) years. Eighty-one of the 89 participants (91%) completed all 4 visits; 3 participants withdrew from the study after the first visit, and 5 participants completed 3 visits. Of the 343 total observations, only 8 (2.3%) were omitted because they corresponded with time-activity questionnaires that were not filled in, and an additional 2 (0.6%) were omitted because medications that might affect biomarker outcomes had been taken by the participants. All participants who attended at least 1 visit were included in the analyses. Ozone was the only pollutant measured to have negative correlations with other pollutants, with the 2-week O 3 exposure more strongly negatively correlated (eTable 4 in the Supplement). In contrast, PM 2.5 ,N O 2 , and SO 2 concentrations were all positively correlated with each other. The 24-hour and 2-week exposure concentrations for all the pollutants were positively correlated with their respective outdoor concentrations.
Air Pollution Exposure
Biomarker Responses
Biomarker concentrations and values are summarized in Table 3 . Using these values in single-pollutant models, we found that a 10-ppb increase in 24-hour O 3 exposure concentration ( Figure 1 In contrast, the single-pollutant models showed that PM 2.5 , NO 2 , and SO 2 exposure concentrations all appear to be associated with fewer biomarkers than O 3 exposure concentration. Each of these pollutants shared various positive associations with EBC MDA level and AI, with only the 2-week NO 2 exposure concentration significantly associated with increases in EBC MDA level (29.9%; 95% CI, 11.5%-51.2%) as well as the 2-week SO 2 exposure concentration significantly associated with increases in EBC MDA level (258.9%; 95% CI, 92.4%-569.4%) and AI (53.1%; 95% CI, 26.9%-79.3%) after multiple testing correction. Before but not after multiple testing correction, 2-week NO 2 exposure concentration was significantly associated with adverse changes in EBC MDA level (37.5%; 95% CI, 1.5%-86.2%) and FEV 1 level (−2.0%; 95% CI, −3.9% to −0.04%), 2-week SO 2 exposure concentration was associated with a significant worsening of PWV (12.4%; 95% CI, 1.8%-22.9%), 24-hour PM 2.5 exposure concentration was associated with a significant decrease in FVC (−0.2%; 95% CI, −0.3% to −0.005%), and 2-week PM 2.5 exposure concentration was associated with a significant increase in VWF (4.6%; 95% CI, 1.5%-7.8%). Figure 2 illustrates the influence of controlling for a second copollutant on the positive associations that O 3 exposure had with FeNO, EBCNN, 8-OHdG, SBP, DBP, and sCD62P measurements. These biomarkers are highlighted as the ones showing positive associations with O 3 in the single-pollutant models. All other 2-pollutant model results can be found in eFigures 1 through 4 in the Supplement. Only the O 3 associations with sCD62P level remained significant after multiple testing correction and after controlling for a copollutant, although controlling for NO 2 and SO 2 exposure concentration decreased the effect size of the 2-week associations. For the 24-hour O 3 and DBP, FeNO, and EBCNN associations as well as the association between 2-week O 3 and EBCNN, the associations maintained a similar effect size. However, significance was lost after multiple testing correction. In terms of negative (beneficial) associations with O 3 exposure concentration, only the association between 24-hour O 3 and AI maintained a consistent effect size in all 2-pollutant models, although this did not remain significant after multiple testing correction.
For PM 2.5 , the association between 2-week PM 2.5 exposure concentration and increased VWF values remained significant in all the 2-pollutant models, although only before multiple testing correction. In addition, the 24-hour PM 2.5 negative (beneficial) associations with 8-OHdG, SBP, and DBP remained significant in 2-pollutant models, although the DBP association became nonsignificant after multiple testing correction. For NO 2 , only the negative (beneficial) associations between the 2-week exposure and each of SBP and DBP remained significant in all the 2-pollutant models, and this DBP association was only significant before multiple testing correction. In addition, controlling for O 3 exposure concentration showed an increase in sCD62P level associated with 24-hour NO 2 that was significant only before correction. Finally, only the 2-week SO 2 positive association with AI and negative associations with FeNO and sCD62P levels remained significant, although not after multiple testing correction. Neither the FEV 1 :FVC ratio nor the CRP level was significantly associated with exposure to O 3 or other pollutants in any of our statistical models.
The results of the sensitivity analyses did not change our conclusions from the main analysis. The sensitivity analysis models generally had higher Akaike and Bayes information criteria, which are indicators of model overfitting. Therefore, we report the results from the main model analyses.
Discussion
This study's principal finding is that O 3 exposures were positively associated with sCD62P level but not lung function and pulmonary inflammation after controlling for copollutants and multiple testing correction. An independent O 3 association (ie, after copollutant adjustment) was observed with blood pressure, although this association did not remain significant after multiple testing correction. This finding suggests that O 3 exposure may enhance cardiovascular disease risk via platelet activation and increased blood pressure at concentrations lower than those required to cause lung function impairment. This result provides mechanistic evidence for the epidemiologic association observed previously between cardiorespiratory mortality and O 3 exposure at levels largely below the current US Environmental Protection Agency ambient air quality standards, the values of which are partially based on the lower limits of observed lung function decrements following O 3 exposures. For the other measured pollutants, we observed associations that were significant before but not after multiple testing correction in the 2-pollutant models between VWF level and 2-week PM 2.5 exposure concentration and between AI and 2-week SO 2 exposure concentration. Previous studies have suggested a correlation between PM 2.5 concentration and increased endothelial cell dysfunction as indicated by VWF levels. 47 Although SO 2 concentration has not previously been associated with AI, it has been previously associated with the related arterial stiffness marker PWV. 48 In contrast to previous studies, 12 the PM 2.5 ,NO 2 , and SO 2 exposures were, to a large extent, not significantly associated with most of the biomarkers after controlling for copollutants in this study. Previous studies have suggested a plateau in the association between PM 2.5 and health effects at high concentrations
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; thus, the observed concentration changes may have been at levels too high to effect measurable biomarker changes. Counterintuitively, these pollutants even showed beneficial associations with 8-OHdG level (with 24-hour PM 2.5 concentration only), sCD62P level (with 2-week SO 2 concentration only), and SBP level (with 24-hour PM 2.5 and 2-week NO 2 concentrations only) that were robust to controlling for copollutants and multiple testing correction. Given that protective effects are not expected according to the literature and biological plausibility, it is likely that these seemingly beneficial associations are artifacts of these pollutants being positively correlated with some other factors that were negatively correlated with the biomarkers.
It is possible that pollutants correlated with O 3 exposure, including O 3 -derived products, could also be implicated in these novel associations between low-level O 3 exposure and cardiovascular disease risk biomarkers. Ozone reacts quickly with various unsaturated organic compounds in the indoor environment to produce highly reactive gaseous and condensed phase products, such as ultrafine particles.
49 Although the evidence for cardiopulmonary effects of exposure to O 3 -initiated reaction products is inconclusive at environmental concentrations, 50 there is evidence supporting a link between ultrafine particles and cardiovascular outcomes, including platelet activation and SBP level. 47 However, blood pressure has also been associated with personal exposure to O 3 independent of ultrafine particle concentrations. 40 Ultimately, this study cannot determine whether the observed associations between cardiovascular outcomes and O 3 are caused by the effects of O 3 exposure itself or its reaction products.
Limitations
This natural experiment used the unique exposure conditions of participants spending most of their time in controlled indoor environments. However, it has several limitations. It is impossible to completely rule out the influence of potential uncontrolled confounders, limiting the ability to make causal determinations because of the reliance on uncontrolled longitudinal associations. In addition, our estimates of 2-week exposure concentrations were based on data from four 24-hour questionnaires, a method that is less precise than measuring exposure over a full 2-week period but more precise than simply using ambient concentrations. Although the 24-hour O 3 ,PM 2.5 ,NO 2 , and SO 2 exposures were well characterized, unmeasured pollutants (eg, products of O 3 -initiated reactions) or other unmeasured factors may explain more of the variation in the observed biomarker-pollutant relationships. Uncontrolled residual confounding may have influenced the pollutant-biomarker associations observed in the study, including those counterintuitive associations.
Conclusions
This study provides mechanistic support to previously observed associations between low-level O 3 exposure and cardiovascular disease outcomes. The findings offer insights into possible underlying biological mechanisms, namely, platelet activation and increases in blood pressure. Given that global tropospheric O 3 concentration is rising, 51 it is imperative to determine how to minimize its harms on health. 
eMethods. Supplementary Methods
Subject Characteristics between Filtration Conditions
The experimental period was from Dec. 1, 2014 to Jan. 30, 2015. From Dec. 1 -Dec. 5 and then from Jan. 14 -Jan. 30, participants had identical central air handling units (AHUs) with a mini-bag filter (F8, MERV 12), followed by an electrostatic precipitator (ESP), and then a high-efficiency particulate air (HEPA) filter. This threedevice configuration was installed as part of the central AHUs that separately served each floor of the office building in which the subjects worked, and also as part of one large central AHU for each dorm building in which the subjects lived.
From Dec. 6 -Jan. 13, both the office and dormitory AHUs were modified in one of two ways: (1) the ESP was turned off and the HEPA filter removed while the F8 filter remained in place, or (2) the ESP was turned off while the F8 filter and HEPA filter remained unchanged. Of the original 89 subjects, 3 dropped out after the first biomarker measurement period (Dec. 2 -Dec. 5). Of the remaining 86 subjects, 34 experienced AHU Condition (1) and the remaining 52 experienced AHU Condition (2). The demographic characteristics of the subjects experiencing these AHU condition changes were compared by t-test for continuous variables and chi-squared test for categorical variables, and the p-values of these tests are presented in eTable 1. The only major demographic difference other than the difference in total number was in the proportion of ex-smokers, and this difference approaches statistical significance. However, the total pack-year characteristics do not differ significantly.
Subjects who experienced Condition (1) (i.e., ESP & HEPA) worked on Floor 4, and subjects who experienced Condition (2) (i.e., ESP only) worked on Floor 3 of the same office building. These floors were sealed off from each other and had separate AHUs, and so there was little mixing of the indoor air downstream of the office filtration units. In terms of the dormitories, subjects experiencing Condition (2) stayed in the same dormitories for the entire study, which included dorm buildings #1-6. Subjects experiencing Condition (1) moved from their original dormitories, which included dorm buildings #1-4, on Dec. 6, 2014 into an adjacent building on the same Broad Town campus, dorm building #7, for the remainder of the study. Dorm building #7 had its HEPA filter and ESP removed during the intervention period and reinstalled when the intervention period ended on Jan. 14, 2015 (i.e., from Jan. 14-30 all subjects from both groups experienced the same filtration conditions in both their office and dormitory setting; this was also the case from Dec. 1-5).
Additional Biomarker Measurement Methods
Breath samples were collected using a device that creates a seal around each subject's mouth and uses a one-way valve with activated carbon for scrubbing ambient NO. The subjects breathed in through the NO-scrubbing inlet, and then exhaled through a flow meter into a 4L aluminum bag at a steady flow rate of 6 to 9 L/min. The breath samples were analyzed for FeNO within hours of collection using a chemiluminescence analyzer (Model 42i, Thermo Scientific, Waltham, USA). EBC from 15 minutes of tidal breathing was collected using a condensation device (ECoScreen, Jaeger, Germany) and stored at -30 °C. EBC MDA was analyzed through thiobarbituric acidderivitization and HPLC-fluorescence detection 1 . EBCNN was analyzed with HPLC-UV detection 2 . Spirometry was performed with a Spirolab III (Medical International Research, Rome, Italy), in which the best measures out of three valid expiratory efforts were selected as representative. PWA measurements were performed with a VICORDER (SMT Medical, Würzberg, Germany), including the measurement of SBP, DBP, and AI with a brachial pressure cuff, as well as PWV with carotid and femoral pressure cuffs. The average of three tests was used for evaluating each of the PWA measures.
Indoor Air Monitoring Schedule
Indoor PM 2.5 mass concentration was continuously measured in the two involved office floors during the day (09:00-18:00) and in two dormitory rooms (out of 35 rooms in 7 buildings total) at night (20:00-08:00) using field-calibrated nephelometers (Sidepak AM510, TSI Inc., Shoreview, USA). Daytime indoor O 3 was continuously measured using a single UV absorption monitor (Model 205, 2B Tech., Boulder, USA) first placed in one of the offices from 09:00-11:00, then the other office from 11:00-16:00, and finally 16:00-18:00 in the original office, alternating which office was measured first. During the night (20:00-22:00), indoor O 3 was monitored for two onehour periods in one selected dormitory room each day.
Calculations for 24-Hour Exposure Measures
This section elaborates on the methods used to calculate the 24-hour and 2-week exposure concentrations. The time-activity questionnaires consisted of three sections: (1) personal conditions, (2) activities over the past 7 days, and (3) activities over the past 24 hours. The first section simply asks whether the subject has a respiratory infection or is menstruating and how many hours ago a subject last ate food (covariates labeled RIS, MS, and LA, respectively, in eTable 5), as these could influence the biomarkers evaluated in the study. Subjects were separately asked about any other illnesses or sudden medication changes during each visit. The second section only requested total times in hours that subjects spent in their dormitories, offices, and other places during the past 7 days, as well as specification of the other locations and how many hours were spent in each of those settings. The third section included the most detail, asking over the past 24 hours which specific times (down to the minute) did the subject spend in their dormitories, offices, outside at Broad Town, outside in other environments and where those locations were, inside in other environments and where those locations were, and hours spent in the same room as someone smoking as a measure of secondhand smoke exposure. The "secondhand smoke" times would later be totaled over the 24 hours prior to biomarker sampling ( ) to use as a covariate in the mixed models associating biomarker outcomes with exposure predictors. The questionnaires were given to subjects to fill out during their second session of the biomarker sampling visit when pulse wave analysis, spirometry, and breath and EBC samples were collected, and so this was the start point from which time was counted backwards to get 24-hour, etc. averages. As this could differ from the time of blood and urine sampling (the first session; always 8:00 AM) by up to 9 hours, we also tried separately calculating 24-hour exposures for each pollutant starting from the blood and urine sampling times for use in models with blood and urine sample-derived biomarker outcomes. However, these "blood and urine" exposure means were very highly correlated with the original exposure means ( = 0.93-0.99), and so they were not used in the exposure-biomarker association mixed models.
These 24-hour specific time data were combined with measured and modeled indoor O 3 and PM 2.5 data for the offices and dorms as well as outdoor data for O 3 , PM 2.5 , NO 2 , and SO 2 to calculate a total exposure concentration for each pollutant for each hour. 3.8% of the hourly outdoor pollutant concentration data were missing, and we used linear interpolation to impute these missing values when possible. When measured PM 2.5 values were not available, the modeled indoor PM 2.5 concentrations were based on I/O ratios for dormitories and the main office levels under different AHU conditions. Dormitory PM 2.5 I/O ratios were separated by building and also separately evaluated for subjects who were current smokers, as these dormitories tended to include indoor PM 2.5 sources from the smoking habits of roommates or the subjects themselves, though subjects were asked to refrain from smoking and incense burning in their dorms. Also, no cooking occurred in the dorms, as they did not have kitchens and all meals were provided in nearby cafeterias. Office PM 2.5 I/O ratios were separately evaluated for office Floors 3 and 4. There were few indoor PM 2.5 sources in the offices, as workers were not permitted to cook, burn incense, or smoke there. See eTable 2 for mean location-and filtration-specific I/O ratios for PM 2.5 used to estimate missing indoor PM 2.5 concentration data.
When measured O 3 values were not available, the modeled indoor O 3 concentrations in ppb for either the offices or the dorms were calculated as shown in Equation 1:
Equation 1
These equations use a value of 0.2 for the I/O ratio of O 3 in either the offices or dorms, and add 3 ppb of O 3 to the room air when the ESP is operating. Both the I/O ratio and the additional O 3 are based on measurements conducted in the offices and dorms. These measurements can be understood in the context of a mass balance model for indoor O 3 (Equation 2-3):
Equation 2
where C in (t) and C out (t) are indoor and outdoor ozone concentration at time t, respectively [ppb] ], R is a unit conversion factor ("mg m -3 " of ozone to "ppb" of ozone), filt is the combined ozone removal efficiency of the mini-bag filter and the HEPA filter, v is the air exchange rate [h -1 ], and k d and k h are the first order rate constants for ozone's removal by indoor surfaces and human surfaces, respectively, [h -1 ]. The second and third terms describe sources of indoor ozone -the ESP unit and outdoor-to-indoor transport. We have assumed that the mini-bag filter and HEPA filter share equally in ozone removal, hence " filt /2" in the second term because the ESP was positioned between these two filters. The fourth to sixth terms describe the removal of ozone by ventilation, room surfaces, and human surfaces, respectively. Under steady-state conditions, dC in (t)/dt = 0 and the indoor ozone concentration can be calculated as:
Equation 3
eTable 3 summarizes the values measured in this study for the parameters in Equation 3 (with the exception of R, which is simply the constant used to convert "mg m -3 " of ozone to "ppb" of ozone at 25 o C). Substituting the measured values of these parameters into Equation 3 results in a value of approximately 0.2 for the I/O ratio of O 3 and an additional 3 ppb of O 3 in the room air when the ESP is operating.
Exposure to each pollutant in a given hour was the product of either (1) the outdoor hourly mean concentration, the location-specific I/O ratio (1.0 for outdoors), and the fraction of the hour spent in that location or (2) the time spent in the location and the measured or modeled indoor concentration. The I/O ratio for unknown indoor environments was 0.35 for O 3 and 0.8 for PM 2.5 . All indoor environments were treated the same for NO 2 and SO 2 , which had assumed I/O ratios of 0.8 and 0.5, respectively. The exposures for each location within each hour were summed to account for all 60 minutes in each hour, and these hourly exposures were averaged over 24 hours to get the mean 24-hour exposure. This is summarized in the following general equation, Equation 4, in which is the one-hour exposure for a given hour and pollutant , is location " " for number of locations at which the subject spent time during that given hour, and are the time and I/O ratios for that given location and pollutant , and is the concentration of pollutant :
Calculations for 2-Week Exposure Measures
The 2-week exposure concentration was calculated using the average of the 4 questionnaires (1 from each visit) for each subject to get subject-specific average times in each location for each hour of the day. This was combined with modeled indoor and measured outdoor concentration data for each hour in the 312 hours before the already calculated 24-hour pre-biomarker measurement period to get a 336-hour (2-week) average exposure concentration. The exposure for a given pollutant p at a given hour h in the 25-336 hours prior to biomarker sampling was calculated using Equation 4, but with the average time spent in each location over the four questionnaires for each subject ( ) used in place of . The aforementioned methods for estimating unknown hourly pollutant concentrations for calculating the 24-hour exposure concentrations were the same for the 2-week calculation except for those times during which subject were believed to have been away from Broad Town. For hours assumed to have been spent away, information about when the subject normally leaves Broad Town was combined with total weekly times spent in the dormitories, offices, and other environments to make an estimate of where each subject was at a given hour. Missing values for the total weekly times were substituted with the mean times for all subjects. Subjects had three consistent patterns for how often they would leave Broad Town during the week: (1) they would stay on or near the campus all week (henceforth called "L1"); (2). they would go to a different residence a short drive away from Broad Town over the weekends (henceforth called "L2"); or (3) they would leave on the weekends and also on Wednesday evenings (henceforth called "L3").
The estimated times in each location during the weekends were calculated based on differences between the written weekly times spent in the dorms, offices, and outdoors and the sum of the assumed time spent in these environments during the week based on the questionnaire data. It was known that the subjects may have spent time outdoors and in the offices over the weekend, most likely between 8:00 AM and 8:00 PM. It was also known that the subjects may have spent time in their dorms over the weekends too, with the greatest likelihood being between 8:00 PM and 8:00 AM, but also some possibility of short visits between 8:00 AM and 8:00 PM. The differences in dorm times, office (work) times, and outdoor times are henceforth abbreviated , , and , respectively.
Based on common time-activity patterns during the weekends reported by the subjects, we assigned the unaccounted-for weekly total time spent in the dorms, offices, and outdoors ( , , and ) to different blocks of time during which subjects were most likely to be in a given location. For example, if was greater than zero, it was assumed that this time was either spent at some point between 8:00 AM -8:00 PM just on Saturday (when was between 0 -8 hours) or split evenly between Saturday and Sunday from 8:00 AM -8:00 PM (when was between 8 -24 hours). Though we have a good estimation of the total time spent in each time period (e.g., 12-hour daytime time period) in a given location, we are not sure exactly which hours would be spent in a given location. Therefore, each hour was weighted equally as shown in 
